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Abstract
Background: To determine the time and temperature stability of whole blood lactate using experimental
conditions applicable to the out-of-hospital environment.
Findings: We performed a prospective, clinical laboratory-based study at an academic hospital. Whole blood
lactate was obtained by venipuncture from five post-prandial, resting subjects. Blood was stored in lithium
heparinized vacutainers in three temperature conditions: 1) room temperature (20°C), 2) wrapped in a portable,
instant ice pack (0°C), or 3) wet ice (0°C). Lactate concentrations (mmol/L) were measured at 0, 5, 10, 20, and 30
minutes after sampling, and compared using repeated measures analysis of variance.
Mean baseline lactate among resting subjects (N = 5) was 1.24 mmol/L (95%CI: 0.49,1.98 mmol/L). After 30
minutes, lactate concentration increased, on average, by 0.08 mmol/L (95%CI: 0.02,0.13 mmol/L), 0.18 mmol/L (95%
CI: 0.07,0.28 mmol/L), and 0.36 mmol/L (95%CI: 0.24,0.47 mmol/L) when stored in wet ice, ice pack, and room
temperature, respectively. The increase in lactate was similar in samples wrapped in portable ice pack or stored in
wet ice at all time points (p > 0.05), and met criteria for equivalence at 30 minutes. However, lactate
measurements from whole blood stored at room temperature were significantly greater, on average, than wet ice
or portable ice pack within five and ten minutes, respectively (p < 0.05).
Conclusions: Whole blood lactate measurements using samples stored in a portable ice pack are similar to wet ice
for up to 30 minutes. These conditions are applicable to the out-of-hospital environment, and should inform future
studies of pre-hospital measurement of lactate.
Background
Early recognition of critical illness may lead to improved
risk stratification, prognostication, and application of
life-saving treatment. Practitioners often use blood lac-
tate, an easily-measured biomarker in hospital emer-
gency care settings, to identify critically ill patients at
greater risk for organ dysfunction, occult hypo-perfu-
sion, and mortality. Lactate concentrations may also
inform treatment decisions, such as the initiation of
early-goal directed therapy in septic shock or traumatic
injury [1,2].
For both injured and non-injured patients, early recog-
nition and triage of critically ill persons occurs before
hospital arrival. Out-of-hospital triage models that iden-
tify patients at greatest risk for critical illness may be
accurate, but require additional sophistication to reduce
under and over triage [3]. To this end, out-of-hospital
biomarkers, such as pre-hospital lactate, offer a potential
method to improve discrimination [4]. During emer-
gency medical services (EMS) care, blood lactate could
be measured from whole blood specimens obtained dur-
ing venipuncture which are transported to hospital
laboratories or from handheld, portable devices [5].
Handheld devices for point-of-care (POC) lactate or
arterial blood gas analysis are validated in hospital-based
settings [5], and are a potential triage tool in the EMS
care of the critically ill. Yet, this approach is not
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considerations. One concern is the time-dependent sta-
bility of the sample. Venous samples may be readily
available after intravenous catheterization by EMS, yet
little data guides post-sampling conditions during EMS
transport. Future comparative studies of POC lactate
may also be informed by a referent standard using
venous whole blood. These studies are challenging due
to: 1) variability in out-of-hospital intravenous catheteri-
zation and venous sampling rates, 2) extended transport
times of whole blood samples to central laboratories (>
15 minutes), and 3) well-recognized, pre-analytical
instability of whole blood lactate during room-tempera-
ture storage or transport [6].
In this study, we sought to determine the temperature
and time stability of venous, whole blood lactate mea-
surements in healthy volunteers using both time inter-
vals and storage methods applicable to the out-of-
hospital environment.
Materials and methods
We conducted a prospective, laboratory-based cohort
study in five healthy volunteers. We obtained whole
blood in three 5 mL lithium heparin vacutainer tubes
(Becton Dickinson, Franklin Lakes, New Jersey) from
five seated, postprandial volunteers through antecubital
fossa venipuncture. We measured whole blood lactate
(mmol/L) from each tube on the ABL800 blood gas
instrument (Radiometer, Westlake, OH) immediately,
and at 5, 10, 20, and 30 minutes after the initial mea-
surement on each tube. The tubes were maintained at
different temperatures after the initial measurement: 1)
20°C - room temperature 2) 0°C-wrapped in portable ice
pack (Instant Cold Pack, Kimberly-Clark, Roswell, GA),
and 3) 0°C-wet ice (referent condition).
We evaluated differences in mean lactate concentra-
tion across time and temperature conditions with
repeated measures, two-way analysis of variance
(ANOVA). We used Bonferroni post-tests to determine
if pairwise differences reached statistical significance (p
< 0.05). Mean change in lactate values at each time
point are plotted with 95% confidence interval for each
temperature condition. We decided a priori that a clini-
cally significant difference in lactate is 0.2 mmol/L [6].
Because failing to reject the null hypothesis does not
imply equivalence, [7] we evaluated the confidence
interval for the difference in lactate increase (from base-
line) for wet ice and ice pack at 30 minutes. We consid-
ered the difference in the increase in lactate
concentration not clinically significant if the 95% confi-
d e n c ei n t e r v a lf o rt h ed i f f e r e n c ef e l le n t i r e l yb e t w e e n0
and 0.2 mmol/L.
Using the measured assay coefficient of variation of
2%, we estimated that a sample size of five patients was
required to detect a difference between 4 and 4.1 mmol/
L (the minimum change detected by the instrument)
assuming alpha = 0.05 and beta = 0.3. This study was
approved by the University of Washington Institutional
Review Board as part of an ongoing quality assurance
project in the clinical laboratory. All data was analyzed
using Prism 5.0 (GraphPad, La Jolla, CA).
Results
Mean baseline lactate among resting subjects (N = 5)
was 1.24 mmol/L (95%CI: 0.49, 1.98 mmol/L). After 30
minutes (Table 1), lactate concentration increased, on
average, by 0.08 mmol/L (95%CI: 0.02, 0.13 mmol/L),
0.18 mmol/L (95%CI: 0.07, 0.28 mmol/L), and 0.36
mmol/L (95%CI: 0.24, 0.47 mmol/L) when stored in wet
ice, ice pack, and room temperature, respectively. Mean
increase in lactate for room temperature was statistically
greater compared to wet ice within 5 minutes of mea-
surement (Figure 1). This difference remained both sta-
tistically and clinically significant (>0.2 mmol/L)
through 30 minutes after sampling. Mean differences
between ice pack and room temperature were also sta-
tistically significant at 10, 20 and 30 minutes (p < 0.05).
Whole blood lactate differences between wet ice and the
ice pack were not clinically or statistically significant at
any time point (p > 0.05 for all). At 30 minutes, the
mean difference in lactate increase between wet ice and
ice pack was 0.1 mmol/L (95% CI: 0.018, 0.19), less than
the a priori threshold for clinical significance.
Discussion
We observed that whole blood lactate measurements
from specimens wrapped in a portable ice pack were
not clinically or statistically d i f f e r e n tf r o mt h o s es t o r e d
on ice for up to thirty minutes after sampling. Consis-
tent with prior studies, lactate measurements from
whole blood maintained at room temperature were sig-
nificantly increased beyond samples stored at 0°C. These
results inform future studies which seek to measure bio-
markers during out-of-hospital care.
The current results confirm that an easy-to-apply,
portable ice pack maintained stable lactate concentra-
tions for up to thirty minutes. Cold temperatures are
known to slow the reduction of pyruvate to lactate in
phlebotomy samples, and the storage of lactate samples
prior to analysis in wet ice is advocated as the standard
of care. Our experimental system (ice pack at 0°C) pre-
vented clinically-relevant or statistically-significant varia-
bility over time, consistent with multiple studies
evaluating lactate concentrations after pre-analytic time
delays of 30 minutes or longer when maintained on wet
ice [8,9]. Although some reports suggest room tempera-
ture storage is sufficient for delays less than 15 minutes
[10], the current experiment revealed significant
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ture storage.
Strengths
Our results have useful implications. Out-of-hospital
biomarker measurements have the potential to improve
recognition and prognostication for the critically ill in
many ways. For example, pre-hospital lactate
measurements may improve triage in injured patients
[4] or may identify patients who require more intensive
therapies than expected based on clinical physiologic
measures. Key to these steps is accurate measurement of
lactate concentration and rigorous examination of the
reliability of testing devices in the field and/or hospital.
Our experimental conditions provide a comparator for
future studies of handheld measurements. In addition,
Table 1 Lactate values in mmol/L for each volunteer (labeled A-E) in each temperature and time condition
0° Celsius (Wet ice) 0° Celsius (Ice pack) 20° Celsius
Time (minutes) A B C D E A B C D E A B C D E
0 1.2 1.1 1.1 0.9 1.9 1.1 1.1 1.2 0.9 2.1 1.4 1 1.2 0.9 1.8
5 1.1 1.1 1.1 1 1.9 1.2 1.2 1.3 0.9 2.1 1.7 1.1 1.3 0.9 1.9
10 1.2 1.1 1.2 1 1.9 1.2 1.2 1.3 1 2.1 1.7 1.2 1.4 1 2
20 1.3 1.1 1.2 1 1.9 1.3 1.3 1.3 1 2.2 1.6 1.3 1.5 1.1 2.1





































































Figure 1 Change in whole blood lactate over time. Mean change in whole blood, venous lactate observed from time of initial measurement
up to 30 minutes. Error bars represent 95% confidence interval, only upper bar shown for room temperature. * p < 0.05 comparing room
temperature to wet ice, ** p < 0.05 comparing both room temperature to wet ice and room temperature to portable ice pack, respectively.
Open triangles = wet ice (0°C); grey squares = portable ice pack (0°C); black triangles = room temperature (20°C).
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utes, our data demonstrate that whole blood samples
could be safely transported by EMS using an ice pack at
0°C to hospital laboratories for standard assays. These
measurements on pre-hospital samples could directly
inform hospital-based, emergency care soon after hospi-
tal arrival, and serve as a baseline for hospital-based
measurements.
Limitations
The current study has limitations. First, we evaluated
resting subjects, and were unable to determine the tra-
jectory of whole blood lactate measurements obtained
during stress or vigorous exercise. We also did not mea-
sure platelets, white blood cell, or red blood cell counts,
which act as reservoirs for glycolytic enzymes that
increase lactate during specimen storage [6]. Therefore,
the external validity of our findings to patients with sys-
temic inflammatory response or leukocytosis is
unknown, though we suspect the use of healthy subjects
lends a conservative bias. As noted previously [10], the
majority of patients who present with sepsis have initial
lactate concentrations in the normal range. We did not
evaluate anti-glycolytic agents, such as sodium fluoride
or potassium oxalate [8], as fluoride does not signifi-
cantly inhibit glycolysis within the time frame for this
set of experiments [11]. Although arterial lactate may
more accurately reflect tissue hypoperfusion, we did not
study arterial samples due to the difficulties in routine
arterial puncture during pre-hospital care.
Conclusions
In summary, we observed that applying a portable ice
pack to venous whole blood samples prevented both sta-
tistically and clinical significant, pre-measurement
increases in lactate concentrations in contrast to sam-
ples maintained at room temperature. Future studies of
out-of-hospital biomarkers may consider these post-
sampling conditions when studying the role of pre-hos-
pital lactate in patients with critical illness.
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